Mackenzie Financial’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-28,251
Closed -$247K 1800
2025
Q1
$247K Sell
28,251
-25,139
-47% -$317K ﹤0.01% 1450
2024
Q4
$767K Buy
53,390
+21,817
+69% +$344K ﹤0.01% 1016
2024
Q3
$713K Buy
+31,573
New +$653K ﹤0.01% 939
2024
Q2
Sell
-13,405
Closed -$503K 1630
2024
Q1
$503K Buy
+13,405
New +$589K ﹤0.01% 1024
2022
Q2
Sell
-4,191
Closed -$319K 1549
2022
Q1
$319K Sell
4,191
-11,527
-73% -$1.01M ﹤0.01% 1091
2021
Q4
$2.34M Sell
15,718
-6,534
-29% -$1M ﹤0.01% 744
2021
Q3
$3.24M Buy
22,252
+2,074
+10% +$356K ﹤0.01% 653
2021
Q2
$3.95M Buy
20,178
+12,831
+175% +$2.32M 0.01% 602
2021
Q1
$1.33M Buy
7,347
+2,703
+58% +$467K ﹤0.01% 768
2020
Q4
$658K Buy
+4,644
New +$674K ﹤0.01% 782

Other funds holding TXG